Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05545436 | Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer | unknown | Phase 2 | 34 | Third Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Sep 22, 2022 | clinicaltrials |
| NCT05540119 | Swedish Oesophago-Gastric Study(SOEGAS) | unknown | — | 25,000 | Karolinska InstitutetOTHER | 1 | Sep 19, 2022 |
| NCT05528367 | Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | unknown | Phase 2 | 33 | Zhejiang Cancer HospitalOTHER | 1 | Sep 6, 2022 | clinicaltrials |
| NCT05526339 | HFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese Patients | unknown | N/A | 600 | RenJi HospitalOTHER | 1 | Sep 2, 2022 | clinicaltrials |
| NCT05253716 | Immunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric Cancer(CRUCIAL) | unknown | N/A | 696 | Jinling Hospital, ChinaOTHER | 1 | Aug 29, 2022 | clinicaltrials |
| NCT05519202 | Exploratory Clinical Study of Penpulimab Combined With SOX in the Perioperative Treatment of Gastric Cancer | unknown | Phase 2 | 47 | The Central Hospital of Lishui CityOTHER | 0 | Aug 29, 2022 | clinicaltrials |
| NCT05510388 | HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk Patients(HRISK) | unknown | N/A | 450 | RenJi HospitalOTHER | 1 | Aug 22, 2022 | clinicaltrials |
| NCT05024812 | Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | unknown | Phase 1 / Phase 2 | 64 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT05497739 | Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer | unknown | Phase 2 | 68 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 11, 2022 | clinicaltrials |
| NCT05498194 | Computational Prediction and Experimental Validation of Gastric Cancer Associated Neoantigens | unknown | — | 50 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Aug 11, 2022 | clinicaltrials |
| NCT05442138 | A Study on the Potential Benefit of Neoadjuvant Therapy for AGC Patients | unknown | — | 54 | Henan Cancer HospitalOTHER_GOV | 0 | Jul 29, 2022 | clinicaltrials |
| NCT05445401 | Pre-rehabilitation in Neoadjuvant Patients With Gastric Cancer | unknown | N/A | 30 | The First Hospital of Jilin UniversityOTHER | 0 | Jul 27, 2022 | clinicaltrials |
| NCT05470452 | Validating the Safety and Effectiveness of ENDOANGEL Upper Gastrointestinal Endoscope Image Auxiliary Diagnostic Software | unknown | N/A | 340 | The Second Affiliated Hospital of Chongqing Medical UniversityOTHER | 1 | Jul 22, 2022 | clinicaltrials |
| NCT05439993 | Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma | unknown | Phase 1 / Phase 2 | 42 | Hallym University Medical CenterOTHER | 1 | Jul 5, 2022 | clinicaltrials |
| NCT05019794 | Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations(FGFR) | unknown | Phase 2 | 80 | LianBio LLCINDUSTRY | 1 | Jun 27, 2022 | clinicaltrials |
| NCT05397548 | Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric Cancer(UCELMGC) | unknown | — | 700 | Lin ChenOTHER | 1 | Jun 27, 2022 | clinicaltrials |
| NCT05410847 | Nab-paclitaxel Plus Camrelizumab and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells | unknown | Phase 2 | 30 | Hebei Medical UniversityOTHER | 0 | Jun 24, 2022 | clinicaltrials |
| NCT05368636 | Combining Tongue and Gastric Cancer Cascade With Artificial Intelligence | unknown | — | 4,000 | Shandong UniversityOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT04637048 | Observational Study on Patients With Hepatobiliary Tumors | unknown | — | 1,000 | Gang Chen, MDOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT04139135 | A Clinical Study of HLX10 Combined With Chemotherapy Versus Placebo Combined With Chemotherapy for Neoadjuvant/Adjuvant Treatment of Gastric Cancer | unknown | Phase 3 | 642 | Shanghai Henlius BiotechINDUSTRY | 1 | Jun 6, 2022 | clinicaltrials |
| NCT05269056 | Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics | unknown | — | 300 | Zhejiang Cancer HospitalOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT05395780 | A Phase 2 Study to Evaluate the Safety and Efficacy of Max-40279-01 in Patients With Advanced Gastric Cancer or Gastroesophageal Junction Cancer | unknown | Phase 2 | 30 | Maxinovel Pty., Ltd.INDUSTRY | 1 | Jun 2, 2022 | clinicaltrials |
| NCT05396326 | A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer | unknown | Phase 1 | 20 | Shanghai Zhongshan HospitalOTHER | 0 | May 31, 2022 | clinicaltrials |
| NCT05346874 | Neoadjuvant TACiE in Locally Advanced Gastric Cancer | unknown | Phase 2 | 37 | Shanghai Zhongshan HospitalOTHER | 1 | May 26, 2022 | clinicaltrials |
| NCT05390684 | Predictive Model to Early Diagnosis of Anastomotic Leak After Esophagectomy and Gastrectomy.(PROFUGO) | unknown | — | 800 | Hospital Universitario La FeOTHER | 1 | May 25, 2022 | clinicaltrials |
| NCT05361161 | Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC) | unknown | Phase 2 | 60 | Gang WuOTHER | 0 | May 24, 2022 | clinicaltrials |
| NCT05385900 | Immune Combined Targeted and Chemotherapy in Perioperative Treatment of Locally Advanced Gastric Cancer(ICTCPTLAGC) | unknown | N/A | 57 | Xijing HospitalOTHER | 0 | May 23, 2022 | clinicaltrials |
| NCT05238584 | Total Versus Partial Omentectomy in the Treatment of Gastric Cancer(TOPO) | unknown | N/A | 300 | University of DebrecenOTHER | 1 | May 20, 2022 | clinicaltrials |
| NCT04235556 | Integrated Care Pathway in Oncology (PASSION)(PASSION) | unknown | — | 1,800 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 13, 2022 | clinicaltrials |
| NCT02781285 | Effect Study of Clinical Outcomes of Traditional Chinese Medicine to Advanced Gastric Cancer by Propensity Score(ESCOTCMAGCPS) | unknown | — | 1,500 | Shanghai University of Traditional Chinese MedicineOTHER | 1 | May 6, 2022 | clinicaltrials |
| NCT02562963 | Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 120 | Minghui ZhangOTHER | 1 | May 2, 2022 | clinicaltrials |
| NCT05027347 | Detection of Plasma Circulating Tumor DNA in Gastric Cancer | unknown | — | 200 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT05061082 | Genomic Evolution of Metastasis in Gastric Cancer | unknown | — | 20 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT05351398 | The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Gastric Cancer | unknown | — | 54 | Shanghai Minimally Invasive Surgery CenterOTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT05342389 | Camrelizumab Combined With Apatinib Versus Apatinib Alone in the Third-line Treatment of Metastatic Gastric Cancer | unknown | Phase 2 | 68 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT04675866 | Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer | unknown | N/A | 46 | Henan Cancer HospitalOTHER_GOV | 1 | Apr 15, 2022 | clinicaltrials |
| NCT05319392 | Transcriptomic Signatures in Gastric Adenocarcinoma(GAC) | unknown | — | 48 | Sanjay Gandhi Postgraduate Institute of Medical SciencesOTHER_GOV | 1 | Apr 15, 2022 | clinicaltrials |
| NCT05315830 | A Study of HER2 Tumor Vaccine in Patients With Her-2 Positive Gastric/GEJ Adenocarcinoma Esophagogastric | unknown | Phase 1 | 10 | The First Affiliated Hospital of Bengbu Medical UniversityOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT03958019 | Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer(RESTORE II) | unknown | N/A | 120 | University of Dublin, Trinity CollegeOTHER | 1 | Apr 13, 2022 | clinicaltrials |
| NCT05313906 | RC48 Plus AK105 and Cisplatin in Advanced Gastric Cancer | unknown | Phase 2 | 40 | Henan Cancer HospitalOTHER_GOV | 1 | Apr 6, 2022 | clinicaltrials |
| NCT05311189 | Study of HLX10, Trastuzumab and Chemotherapy in First-line Treatment of HER2-positive Recurrent/Metastatic Gastric Cancer | unknown | Phase 2 | 40 | Shanghai Zhongshan HospitalOTHER | 0 | Apr 5, 2022 | clinicaltrials |
| NCT05301465 | Predictive Role of Circulating Angiogenic Factors for Second-line Paclitaxel and Ramucirumab. | unknown | — | 50 | University of PisaOTHER | 1 | Mar 29, 2022 | clinicaltrials |
| NCT04801459 | Study on the Peristaltic Direction of GI Anastomosis in Roux-en-Y Reconstruction | unknown | N/A | 148 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Mar 22, 2022 | clinicaltrials |
| NCT05287672 | Retrospective Study of Effect of Adjuvant Chemoradiation of Gastric Carcinoma on Local Control and Survival | unknown | — | 30 | Assiut UniversityOTHER | 0 | Mar 18, 2022 | clinicaltrials |
| NCT04119622 | Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer | unknown | Phase 2 | 30 | Aiping ZhouUNKNOWN | 1 | Mar 11, 2022 | clinicaltrials |
| NCT05275062 | Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma | unknown | Early Phase 1 | 6 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | Mar 11, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Sep 22, 2022source: clinicaltrials